Stocktoria

Vanda Pharmaceuticals Inc. VNDA

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2006-04-12 · LEI

Vanda Pharmaceuticals Inc. statistics & valuation

Market cap$344.6M
P / S1.6×
P / B1.1×
Net margin-102.0%
Return on equity-67.4%
FCF margin-51.1%
Return on capital-44%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-12.30% -9.40% 13.10% 50.90% 9.40% 12.30% 2.50% 1.30% -9.50% -102.00% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-12.70% -10.20% 11.30% 10.00% 11.00% 15.70% 2.50% -7.20% -20.50% -70.00% 2016201720182019202020212022202320242025
Return on equity (%)
-13.70% -11.80% 9.20% 28.10% 5.10% 6.60% 1.20% 0.50% -3.50% -67.40% 2016201720182019202020212022202320242025
Shares outstanding
44.0M 44.9M 53.0M 54.8M 55.2M 56.9M 57.0M 57.6M 58.3M 59.1M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-8.60% -7.60% 7.60% 23.90% 4.40% 5.60% 1.00% 0.40% -2.90% -45.10% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-6.50% -2.20% 15.30% 19.80% 20.10% 23.70% 12.30% 6.40% -8.20% -51.10% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.41 -$0.35 $0.48 $2.11 $0.42 $0.58 $0.11 $0.04 -$0.33 -$3.74 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Vanda Pharmaceuticals Inc. trades at about 129.8× earnings — above its 10-year norm (10-year range 6×–90×, median 34.1×).

6× 129.8×

Shaded band = 10-year range (6×–90×); dot = today's 129.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-70.0%-20.5%-7.2%2.5%15.7%11.0%10.0%11.3%-10.2%-12.7%
Net margin-102.0%-9.5%1.3%2.5%12.3%9.4%50.9%13.1%-9.4%-12.3%
FCF margin-51.1%-8.2%6.4%12.3%23.7%20.1%19.8%15.3%-2.2%-6.5%
Return on assets-45.1%-2.9%0.4%1.0%5.6%4.4%23.9%7.6%-7.6%-8.6%
Return on equity-67.4%-3.5%0.5%1.2%6.6%5.1%28.1%9.2%-11.8%-13.7%
Current ratio2.394.394.945.686.436.215.955.642.413.46

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.